Literature DB >> 11869895

Transcriptional control of B-cell development.

Michael Schebesta1, Barry Heavey, Meinrad Busslinger.   

Abstract

Significant progress has recently been made in our understanding of how transcription factors such as PU.1, Notch1, E2A, EBF, Pax5, Bcl6, Blimp1 and XBP1 control different developmental decisions during the onset and terminal phase of B-lymphopoiesis. One emerging theme is that negative regulatory networks play an important role in suppressing alternative gene programs and their corresponding cell fates throughout B-cell development.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11869895     DOI： 10.1016/s0952-7915(02)00324-2

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN： 0952-7915            Impact factor:   7.486


  46 in total

1.  Myeloid lineage switch of Pax5 mutant but not wild-type B cell progenitors by C/EBPalpha and GATA factors.

Authors:  Barry Heavey; Christoforos Charalambous; Cesar Cobaleda; Meinrad Busslinger
Journal:  EMBO J       Date:  2003-08-01       Impact factor: 11.598

2.  Insight into lymphoid development by gene expression profiling of avian B cells.

Authors:  Kimmo Koskela; Pekka Kohonen; Pia Nieminen; Jean-Marie Buerstedde; Olli Lassila
Journal:  Immunogenetics       Date:  2003-08-21       Impact factor: 2.846

3.  Normal B-1a cell development requires B cell-intrinsic NFATc1 activity.

Authors:  Robert Berland; Henry H Wortis
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

Review 4.  Contingent gene regulatory networks and B cell fate specification.

Authors:  Harinder Singh; Kay L Medina; Jagan M R Pongubala
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-23       Impact factor: 11.205

5.  Transcription factor MIST1 in terminal differentiation of mouse and human plasma cells.

Authors:  Benjamin J Capoccia; Jochen K M Lennerz; Andrew J Bredemeyer; Jeffery M Klco; John L Frater; Jason C Mills
Journal:  Physiol Genomics       Date:  2010-11-23       Impact factor: 3.107

6.  Suppression of B-cell development genes is key to glucocorticoid efficacy in treatment of acute lymphoblastic leukemia.

Authors:  Karina A Kruth; Mimi Fang; Dawne N Shelton; Ossama Abu-Halawa; Ryan Mahling; Hongxing Yang; Jonathan S Weissman; Mignon L Loh; Markus Müschen; Sarah K Tasian; Michael C Bassik; Martin Kampmann; Miles A Pufall
Journal:  Blood       Date:  2017-04-19       Impact factor: 22.113

7.  Pim1 serine/threonine kinase regulates the number and functions of murine hematopoietic stem cells.

Authors:  Ningfei An; Ying-Wei Lin; Sandeep Mahajan; Joshua N Kellner; Yong Wang; Zihai Li; Andrew S Kraft; Yubin Kang
Journal:  Stem Cells       Date:  2013-06       Impact factor: 6.277

8.  Silencing of microRNA-155 in mice during acute inflammatory response leads to derepression of c/ebp Beta and down-regulation of G-CSF.

Authors:  Jesper Worm; Jan Stenvang; Andreas Petri; Klaus Stensgaard Frederiksen; Susanna Obad; Joacim Elmén; Maj Hedtjärn; Ellen Marie Straarup; Jens Bo Hansen; Sakari Kauppinen
Journal:  Nucleic Acids Res       Date:  2009-07-13       Impact factor: 16.971

9.  Pax5 induces V-to-DJ rearrangements and locus contraction of the immunoglobulin heavy-chain gene.

Authors:  Martin Fuxa; Jane Skok; Abdallah Souabni; Giorgia Salvagiotto; Esther Roldan; Meinrad Busslinger
Journal:  Genes Dev       Date:  2004-02-15       Impact factor: 11.361

10.  Efficient retroviral transduction of human B-lymphoid and myeloid progenitors: marked inhibition of their growth by the Pax5 transgene.

Authors:  Rieko Sekine; Toshio Kitamura; Takashi Tsuji; Arinobu Tojo
Journal:  Int J Hematol       Date:  2008-05       Impact factor: 2.490
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.